Mga Batayang Estadistika
| CIK | 1017110 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to GeneThera, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-S |
|
| February 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-27237 GeneThera, Inc. (Exact name of registrant as spe |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Ex |
|
| August 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Exact n |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR N |
|
| May 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 000-27237 Commission File Number: GeneThera, Inc. (Exact |
|
| May 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2022 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| April 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-27237 GeneThera, Inc. (Exact name of registrant as specif |
|
| March 31, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number 000-27237 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Form N-SAR For the Transition Period Ended: Read instruction (on back page) before preparing form. |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Ex |
|
| October 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 9, 2021 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 12, 2021 |
EXHIBIT 10.1 |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Exact n |
|
| May 18, 2021 |
Exhibit 10.1 CERTIFICATE OF INCORPORATION OF A PRIVATE LIMITED COMPANY Company Number 13353473 The Registrar of Companies for England and Wales, hereby certifies that GENETHERA ROBOTICS LIMITED is this day incorporated under the Companies Act 2006 as a private company, that the company is limited by shares, and the situation of its registered office is in England and Wales. Given at Companies Hous |
|
| May 18, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2021 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2021 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 000-27237 Commission File Number: GeneThera, Inc. (Exact |
|
| April 27, 2021 |
Financial Statements and Exhibits 8-K 1 form-8k.htm GENETHERA, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2021 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of |
|
| April 27, 2021 |
EX-10.1 2 ex10-1.htm COLLABORATION AGREEMENT Exhibit 10.1 CONSULTING AGREEMENT BY AND BETWEEN GENETHERA (“CLIENT”) AND CUMMING MANAGEMENT GROUP, INC. (“CONSULTANT”) FOR PROJECT MANAGEMENT SERVICES Page 1 of 5 CONSULTING AGREEMENT This Consulting Agreement “Agreement” is entered into by and between Cumming Management Group, Inc. (“CMGI”) hereinafter referred to as “Consultant” and GeneThera hereina |
|
| April 14, 2021 |
Annual Report - GENETHERA, INC. 10-K 10-K 1 form-10k.htm GENETHERA, INC. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2020. OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-27237 GeneThera |
|
| March 31, 2021 |
NT 10-K 1 genetherant10k.htm GENETHERA, INC. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ |
|
| November 18, 2020 |
10-Q/A 1 genethera10q-18187.htm GENETHERA, INC. 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSI |
|
| November 16, 2020 |
Quarterly Report - GENETHERA, INC. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 000-27237 Commission File Number: GeneThera, Inc. (Ex |
|
| September 21, 2020 |
Annual Report - GENETHERA, INC. 10-K/A, AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-27237 GeneThera, Inc. (Exact name of |
|
| September 10, 2020 |
Quarterly Report - GENETHERA, INC. 10-Q/A, AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneT |
|
| August 14, 2020 |
Quarterly Report - GENETHERA, INC. 10-Q 10-Q 1 form-10q.htm GENETHERA, INC. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File N |
|
| August 13, 2020 |
Quarterly Report - GENETHERA, INC. 03/31/2020 10-Q/A, AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneT |
|
| June 24, 2020 |
Quarterly Report - GENETHERA, INC. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Exact |
|
| June 10, 2020 |
Annual Report - GENETHERA, INC. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-27237 GeneThera, Inc. (Exact name of registrant as specif |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 14, 2020 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of (Commission (IRS Employer incorporation |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 14, 2020 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of (Commission (IRS Employer incorporation |
|
| March 31, 2020 |
GTHR / GeneThera, Inc. 10-Q - Quarterly Report - GENETHERA, INC. 09/30/2019 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Ex |
|
| March 30, 2020 |
GTHR / GeneThera, Inc. NT 10-K - - GENETHERA, INC. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o |
|
| March 30, 2020 |
GTHR / GeneThera, Inc. 10-Q - Quarterly Report - GENETHERA, INC. 06/30/2019 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Exact n |
|
| March 26, 2020 |
GTHR / GeneThera, Inc. 10-Q - Quarterly Report - GENETHERA, INC.03/31/2019 10-Q 10-Q 1 form-10q.htm GENETHERA, INC.03/31/2019 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commis |
|
| March 9, 2020 |
Dismissal Letter of BFBorgers, CPA, PC March 8, 2020 Ben F Borgers B F Borgers CPA PC 5400 W Cedar Ave Lakewood, co 80226 We have engaged MaughanSullivan LLC to audit our financial statements for the year ended December 31, 2019. |
|
| March 9, 2020 |
8-K 1 genethera8k-17901.htm GENETHERA, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 9, 2020 GENETHERA, INC. (Exact name of Registrant as specified in its charter) NEVADA 000-27237 65-0622463 (State or other jurisdi |
|
| February 27, 2020 |
List of subsidiaries of the Company Exhibit 21.1 List of Subsidiaries GeneThera, Inc., a Colorado corporation |
|
| February 27, 2020 |
GTHR / GeneThera, Inc. 10-K - Annual Report - GENETHERA, INC. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-27237 GeneThera, Inc. (Exa |
|
| March 29, 2019 |
GTHR / GeneThera, Inc. GENETHERA NT 10-K NT 10-K 1 genetherant-17635.htm GENETHERA NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr |
|
| December 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2018 (December 6, 2018) GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdictionof incorporation) ( |
|
| December 13, 2018 |
Letter of Resignation from Fred Oeschger EXHIBIT 99.1 |
|
| December 4, 2018 |
Exhibit A of The Milestone Investment Agreement EX-10.1 2 exhibit10-1.htm EXHIBIT A OF THE MILESTONE INVESTMENT AGREEMENT EXHIBIT 10.1 |
|
| December 4, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2018 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 3, 2018 |
GTHR / GeneThera, Inc. GENETHERA, INC. JUNE 30, 2018 10-Q/A, AMENDMENT NO. 1 (Quarterly Report) 10-Q/A 1 genethera10qa-17545.htm GENETHERA, INC. JUNE 30, 2018 10-Q/A, AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE |
|
| December 3, 2018 |
GTHR / GeneThera, Inc. GENETHERA, INC. MARCH 31, 2018 10-Q/A, AMENDMENT NO. 1 (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneT |
|
| November 30, 2018 |
GTHR / GeneThera, Inc. GENETHERA, INC. MARCH 31, 2018 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Exact |
|
| November 30, 2018 |
EX-10.1 4 exhibit101-milestoneex10z1.htm EXHIBIT 10.1 |
|
| November 30, 2018 |
Exhibit 21.1 List of Subsidiaries GeneThera, Inc., a Colorado corporation |
|
| November 30, 2018 |
EX-3.3 3 exhibit33bylawsex3z3.htm EXHIBIT 3.3 BYLAWS ARTICLE I OFFICES Section 1. The registered office shall be located in Denver, Colorado. Section 2. The corporation may also have offices at such other places both within and without the State of Colorado and/or Nevada where the Charter is incorporated as the board of directors may from time to time determine or the business of the corporation m |
|
| November 30, 2018 |
GTHR / GeneThera, Inc. GENETHERA, INC. SEPTEMBER 30, 2018 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, Inc. (Ex |
|
| November 30, 2018 |
EX-10.4 7 exhibit104emplagrex10z4.htm EXHIBIT 10.4 EMPLOYMENT AGREEMENT IRIZARRI |
|
| November 30, 2018 |
GTHR / GeneThera, Inc. GENETHERA, INC. JUNE 30, 2018 10-Q (Quarterly Report) 10-Q 1 genethera10q-17542.htm GENETHERA, INC. JUNE 30, 2018 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD F |
|
| November 30, 2018 |
, an entity having an address at 6860 Broadway, Denver, CO 80221 EX-10.2 5 exhibit102subleaseex10z2.htm EXHIBIT 10.2 SUBLEASE SUBLEASE THIS SUBLEASE is made as of the 1st day of January 2018, by and between GTI RESEARCH, INC., an entity having an address at 6860 Broadway, Denver, CO 80221 (“Sublandlord”) and GeneThera, Inc., a Nevada corporation with an address at 6860 Broadway, Unit B, Denver, CO 80221 (“Subtenant”). RECITALS A. Pursuant to a certain Lease, da |
|
| November 30, 2018 |
GTHR / GeneThera, Inc. 10K 2017 (Annual Report) 10-K 1 superform10k10k.htm 10K 2017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2017 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fil |
|
| November 30, 2018 |
GENETHERAINC CODE OF CONDUCT FOR THE BOARD MEMBERS AND SENIOR MANAGEMENT OF GENETHERA INC GENETHERAINC CODE OF CONDUCT FOR THE BOARD MEMBERS AND SENIOR MANAGEMENT OF GENETHERA INC This Code has been approved by the Board of Directors of the Company vide Board resolution dated 29th December, 2004. |
|
| November 30, 2018 |
Converted by EDGARwiz |
|
| November 30, 2018 |
Converted by EDGARwiz |
|
| September 12, 2018 |
8-K 1 8kchangeofauditor912188k.htm FORM 8K CHANGE OF AUDITORS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 12, 2018 GENETHERA, INC. (Exact name of Registrant as specified in its charter) NEVADA (State or other jurisdict |
|
| September 12, 2018 |
EX-10.1 2 exhibit10.1ex10z1.htm EXHIBIT 10.1 September 12, 2018 Kory Robert Kolterman Fruci & Associates II, PLLC 802 N. Washington St. Spokane, WA 99201 Re: Kory Robert Kolterman and Fruci & Associates’ Dismissal Dear Kory, This letter is to inform you and Fruci & Associates CPA Firm that effective immediately we are dismissing your CPA firm as auditors of GeneThera Inc. This decision is due, in |
|
| September 12, 2018 |
GTHR / GeneThera, Inc. 10K 2016 (Annual Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-27237 GeneThera, Inc. (Exact name of registrant as Spec |
|
| September 12, 2018 |
Exhibit 21.1 Subsidiaries GeneThera, Inc., a Colorado corporation, is a subsidiary for GeneThera, Inc., a Nevada Corporation. |
|
| August 31, 2018 |
8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2018 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 28, 2018 |
GTHR / GeneThera, Inc. FORM 10Q (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneTh |
|
| November 14, 2016 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): (X)Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2016 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition R |
|
| August 22, 2016 |
GeneThera FROM 10Q/A AMENDMENT NO1 (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NUMBER 1 FORM 10-Q/A [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: |
|
| August 22, 2016 |
GeneThera FROM 10Q/A AMENDMENT NO1 (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NUMBER 1 FORM 10-Q/A [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: |
|
| August 22, 2016 |
GeneThera FORM 10Q (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, |
|
| August 22, 2016 |
GeneThera FORM 10Q (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, |
|
| August 12, 2016 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: June 30, 2015 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| May 23, 2016 |
GeneThera FORM 10Q (Quarterly Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, |
|
| May 16, 2016 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: March 31, 2016 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| May 13, 2016 |
GeneThera FORM 10K (Annual Report) 10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM Commission File Number: 000-27237 GeneThera, Inc. (E |
|
| March 30, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 23, 2015 |
10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneTh |
|
| November 16, 2015 |
GeneThera NOTICE OF LATE FILING OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response. 2.50 FORM 12b-25 SEC FILE NUMBER 000-27237 CUSIP NUMBER NOTIFICATION OF LATE FILING 37185E306 (Check one): [] Form 10-K [] Form 20-F [] Form 11-K [X] Form 10-Q [] Form 10-D [] Form N-SAR [] Form N-CSR For Period Ended: Sept |
|
| August 19, 2015 |
10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 000-27237 GeneThera, |
|
| August 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: June 30, 2015 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| May 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2015 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer I |
|
| May 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: March 31, 2015 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| April 21, 2015 |
8-K 1 form8kbodappointments.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2015 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incor |
|
| April 14, 2015 |
Exhibit 21.1 Subsidiaries GeneThera, Inc., a Colorado Corporation, is a subsidiary for GeneThera, Inc., a Nevada Corporation. GeneThera Subsidiary is still in Colorado. |
|
| April 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM 01/01/2014 TO 12/31/2014 Commission File Number: 000-27237 Ge |
|
| March 27, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): (X)Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: December 31, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N |
|
| March 4, 2015 |
Financial Statements and Exhibits 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 4, 2015 |
Converted by EDGARwiz |
|
| March 4, 2015 |
GENETHERA ENTERS INTO EXCLUSIVE COLLABORATION AGREEMENT WITH HUDSON ROBOTICS INC. Converted by EDGARwiz GENETHERA ENTERS INTO EXCLUSIVE COLLABORATION AGREEMENT WITH HUDSON ROBOTICS INC. |
|
| February 3, 2015 |
Exhibit 16.1 January 30, 2015 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 We have read Item 4.01 included in the Form 8-K dated January 30, 2015 of GeneThera, Inc. to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm. Sincerely, /s/: John Malone MaloneBailey, LLP Houston, |
|
| February 3, 2015 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2015 GeneThera, Inc. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2014 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employ |
|
| November 13, 2014 |
GTHR / GeneThera, Inc. NT 10-Q/A - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N |
|
| November 13, 2014 |
GTHR / GeneThera, Inc. NT 10-Q - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N |
|
| August 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2014 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer In |
|
| August 13, 2014 |
GTHR / GeneThera, Inc. NT 10-Q - - LATE FILING NOTIFICATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: June 30, 2014 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2014 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer I |
|
| April 15, 2014 |
10k 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM 01/01/2013 TO 12/31/2013 Commission File Number: 000 |
|
| April 15, 2014 |
Exhibit 21.1 Subsidiaries GeneThera, Inc., a Colorado corporation, is a subsidiary for GeneThera, Inc., a Nevada Corporation. GeneThera Subsidiary will no longer be in Colorado. GeneThera, Inc. has a subsidiary located in Monterrey, Mexico by the name of Applied Genetics S.A. |
|
| March 31, 2014 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): (X)Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: December 31, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Re |
|
| December 16, 2013 |
GeneThera, Inc. Consolidated Balance Sheets (Unaudited) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2013 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 6 |
|
| November 14, 2013 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Re |
|
| September 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2013 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer |
|
| August 16, 2013 |
GeneThera, Inc. Consolidated Balance Sheets (Unaudited) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2013 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-062 |
|
| August 14, 2013 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: June 30, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2013 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer I |
|
| May 15, 2013 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: March 31, 2013 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| April 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM 01/01/2012 TO 12/31/2012 Commission File Number: 000-27237 Ge |
|
| March 29, 2013 |
- GENETHERA, INC. FORM 12B-25 FOR DECEMBER 31, 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): (X)Form 10-K ()Form 20-F ()Form 11-K ()Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: December 31, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N- |
|
| November 19, 2012 |
Converted by EDGARwiz GeneThera, Inc. Consolidated Balance Sheets (Unaudited) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2012 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in |
|
| November 14, 2012 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Re |
|
| September 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 28, 2012 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2012 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of ( |
|
| August 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2012 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer In |
|
| August 14, 2012 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: June 30, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| May 18, 2012 |
EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (the “Agreement”), dated as of the 8th day of January 2012, between GeneThera, Inc. |
|
| May 18, 2012 |
8-K 1 8kagagreement.htm 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2012 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction Of incorporatio |
|
| May 18, 2012 |
APPLIED GENETICS SIGNS AGREEMENT WITH THE NATIONAL UNIVERSITY OF MEXICO (UNAM) EX-99.1 CHARTER 5 pr4appliedgeneticssignsagree.htm PRESS RELEASE DATED MAY16, 2012 ANNOUNCING APPLIED GENETICS SIGNING AGREEMENT WITH UNAM APPLIED GENETICS SIGNS AGREEMENT WITH THE NATIONAL UNIVERSITY OF MEXICO (UNAM) Westminster, CO PRNewswire May 16, 2012; GeneThera Inc. (OTCQB: GTHR) announced today that Applied Genetics, GeneThera’s majority owned subsidiary, signed a research and test validat |
|
| May 18, 2012 |
EMPLOYMENT AGREEMENT EMPLOYMENT AGREEMENT (the “Agreement”), dated as of the 8th day of January 2012, between GeneThera, Inc. |
|
| May 18, 2012 |
FOR “LA UNAM”: DR. EDUARDO BÁRZANA GARCÍA, SECRETARY GENERAL REGISTRATION NUMBER: 29495-1575-10-VIII-11 THIS IS A JOINT-VENTURE AGREEMENT REACHED BY LA UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO (IN ENGLISH, “THE NATIONAL AUTONOMOUS UNIVERSITY OF MEXICO”), HEREINAFTER CALLED “LA UNAM”, REPRESENTED IN THIS ACTION BY ITS SECRETARY GENERAL, DR. |
|
| May 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2012 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Inc |
|
| May 15, 2012 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: March 31, 2012 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report |
|
| April 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM 01/01/2011 TO 12/31/2011 Commission File Number: 000-27237 Ge |
|
| April 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2011 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction |
|
| April 6, 2012 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 29, 2012 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): (X)Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2011 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition R |
|
| March 5, 2012 |
MARKETING AND SALE AGREEMENT MARKETING AND SALE AGREEMENT This Marketing and Sales Agreement (the Agreement) is made this 1st day of February, 2012, by and among Nutrición Avanzada S. |
|
| March 5, 2012 |
Financial Statements and Exhibits - 8K 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2012 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission (I.R |
|
| March 5, 2012 |
APPLIED GENETICS SIGNS MARKETING AND SALES AGREEMENT WITH NUTRICION AVANZADA APPLIED GENETICS APPOINTS DR APPLIED GENETICS SIGNS MARKETING AND SALES AGREEMENT WITH NUTRICION AVANZADA February 22, 2012 PRNewswire, GeneThera, Inc. |
|
| January 26, 2012 |
Converted by EDGARwiz “APPLIED GENETICS, S.A. DE C.V.” ORDINARY SHAREHOLDERS MEETING On January 3rd, 2012 at 10:00 hours in the city of Monterrey, Nuevo Leon, Mexico at the office address of the company named “Applied Genetics, S.A. de C.V.”, shareholders met in order to have a Shareholders Meeting to which they have been previously called in person by the company’s administration, while the compa |
|
| January 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2012 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 26, 2012 |
GENETHERA, INC. ACQUIRES APPLIED GENETICS, S.A. APPLIED GENETICS APPOINTS DR GENETHERA, INC. ACQUIRES APPLIED GENETICS, S.A. January 25, 2012 GeneThera, Inc. (OTCQB: GTHR) announced today that has acquired a majority ownership of Applied Genetics, a molecular diagnostic company based in Monterrey, Mexico. Applied Genetics is a molecular diagnostic company that focuses on commercializing molecular testing for Johne’s disease in Mexico. This acqu |
|
| January 18, 2012 |
REGULAR GENERAL MEETING OF SHAREHOLDERS OF “APPLIED GENETICS, S.A. DE C.V.” ASAMBLEA GENERAL ORDINARIA DE ACCIONISTAS REGULAR GENERAL MEETING OF SHAREHOLDERS OF “APPLIED GENETICS, S. |
|
| January 18, 2012 |
APPLIED GENETICS APPOINTS DR. MILICI INTERIM PRESIDENT APPLIED GENETICS APPOINTS DR APPLIED GENETICS APPOINTS DR. MILICI INTERIM PRESIDENT Westminster, CO, January 10, 2012 (MARKET WIRE) - GeneThera, Inc. (OTCQB:GTHR - News), GeneThera, Inc. announced today that Applied Genetics has appointed Dr. Tony Milici as the new Interim President of Applied Genetics, S.A. de C.V., which is located in Monterrey, Mexico. This is a joint venture between Nutrición |
|
| January 18, 2012 |
ITEM 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2012 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission F |
|
| November 23, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2011 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of Incorporation or Organization) (I |
|
| November 21, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2011 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporati |
|
| November 21, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2011 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation o |
|
| November 21, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2010 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation |
|
| November 21, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2010 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or |
|
| November 21, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [x] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2010 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporati |
|
| November 18, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2010 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation o |
|
| November 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (x)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: September 30, 2011 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N |
|
| November 14, 2011 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2009 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporati |
|
| November 4, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2010 Commission File Number: 000-27237 GeneThera, Inc. (Exact name of registrant as Specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (Internal Revenue Service Incorpor |
|
| November 3, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2009 Commission File Number: 000-27237 GeneThera, Inc. (Exact name of registrant as Specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (Internal Revenue Service Incorpor |
|
| November 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2008 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on F |
|
| October 8, 2009 |
W. T. UNIACK & CO. CPA?S, P.C. CERTIFIED PUBLIC ACCOUNTANTS 1003 Weatherstone Pkwy., Ste. 320 12600 Deerfield Pkwy., Ste 100 Woodstock, GA 30188 Alpharetta, GA 30004 Phone: 770-592-3233 Phone: 678-566-3774 October 2, 2009 Securities and Exchange Commission Mail Stop 11-3 450 5th Street, N.W. Washington, D.C. 20549 Dear Sirs/Madams: With regard to item 4.01, we disagree with Company?s assertion in |
|
| October 8, 2009 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 31, 2009 GENETHERA, INC. (Exact name of Registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 000-27237 (Commission File Number) 65-062246 |
|
| August 28, 2009 |
EX-16 4 genetheraresignationletter1.htm RESIGNATION LETTER OF PREVIOUS AUDITORS W. T. UNIACK & CO. CPA’S, P.C. CERTIFIED PUBLIC ACCOUNTANTS 1003 Weatherstone Pkwy., Ste. 320 12600 Deerfield Pkwy., Ste 100 Woodstock, GA 30188 Alpharetta, GA 30004 Phone: 770-592-3233 Phone: 678-566-3774 June 16, 2009 Antonio Milici, Chairman of the Board of Directors Tannya Irizarry, Chief Accounting Officer GeneThe |
|
| August 28, 2009 |
EX-18 5 genethera8kresponse.htm RESPONSE OF PREVIOUS AUDITORS W. T. UNIACK & CO. CPA’S, P.C. CERTIFIED PUBLIC ACCOUNTANTS 1003 Weatherstone Pkwy., Ste. 320 12600 Deerfield Pkwy., Woodstock, GA 30188 Alpharetta, GA 30004 Phone: 770-592-3233 Phone: 678-566-3774 July 27, 2009 Securities and Exchange Commission Mail Stop 11-3 450 5th Street, N.W. Washington, D.C. 20549 Dear Sirs/Madams: We have read I |
|
| August 28, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 13, 2009 GENETHERA, INC. (Exact name of Registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 33-142603 (Commission File Number) 65-062 |
|
| August 28, 2009 |
Converted by EDGARwiz May 27, 2009 GENETHERA INC. BOARD OF DIRECTORS Special Conference Call Meeting Present: Dr. Tony Milici Tannya Irizarry Joe Sandoval Not Present: Dr. Thomas Slaga BOARD RESOLUTION SUBJECT: Dismissal of Auditors The Chairman of The Board approved the dismissal of the auditors W.T. UNIACK & CO. CPA’s, P.C. after validating their disregard of the rules and regulations of the SEC |
|
| August 28, 2009 |
GENETHERA INC BOARD RESOLUTION EX-17 3 exhibit17mb.htm BOARD RESOLUTION ENGAGEMENT OF NEW AUDITORS GENETHERA INC BOARD RESOLUTION SUBJECT: ENGAGEMENT OF INDEPENDENT AUDITORS DATE: JULY 22, 2009 METHOD: VIA CONFERENCE CALL TO ITALY PARTICIPANTS: KEVIN SCOTT, COO TANNYA IRIZARRY, CFO INTERIM DR. ANTONIO MILICI, CHAIRMAN OF THE BOARD AND CEO WHEREAS, THE CHAIRMAN OF THE BOARD APPROVED THE ENGAGEMENT OF MALONE-BAILEY, P.C. AS OUR N |
|
| August 26, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2009 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation |
|
| August 24, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2009 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation |
|
| August 24, 2009 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2009 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or |
|
| August 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ()Form 10-K ()Form 20-F ()Form 11-K (X)Form 10-Q ()Form 10-D ()Form N-SAR ()Form N-CSR For Period Ended: March 31, 2008 Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K Transition Report on Form 10-Q Transition Report on Form N-SAR |
|
| August 13, 2009 | ||
| July 28, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2009 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2008 Commission File Number: 000-27237 GeneThera, Inc. (Exact name of registrant as Specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (Internal Revenue Service Incorp |
|
| June 26, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2007 Commission File Number: 000-27237 GeneThera, Inc. (Exact name of registrant as Specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (Internal Revenue Service Incorp |
|
| December 10, 2008 |
Schedule 13G Final Amendment 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 4, 2008 |
EX-16 2 exhibit161jaspers.htm PREVIOUS AUDITORS CONSENT Exhibit 16.1 December 3, 2008 U.S. Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: GeneThera, Inc. We have read the statements that GeneThera, Inc. included under Item 4.01 of the Current Report on Form 8-K/A expected to be filed on December 3, 2008 regarding the recent change of auditors. We agree with su |
|
| December 4, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 14, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 33-142603 65-0622463 (State or other jurisdiction (Commission (IRS Employer of incorpo |
|
| November 24, 2008 |
ALG-CL-1 JASPERS + HALL, PC CERTIFIED PUBLIC ACCOUNTANTS 7900 E Union Avenue, Suite 900 Denver, CO 80237 October 21, 2008 Tannya Irizarry Genethera, Inc. Via email Dear Tannya: Effective October 21, 2008, we are no longer registered with the PCAOB and therefore must resign as your auditor. Sincerely, Thomas M. Jaspers Thomas M. Jaspers |
|
| November 24, 2008 |
UNITED STATES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 24, 2008 GENETHERA, INC. (Exact name of Registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 33-142603 (Commission Fil |
|
| November 24, 2008 |
W. T. Uniack & Co. CPA’s P.C. 12600 Deerfield Parkway Suite 100 Alpharetta, Georgia 30004 EX-10 2 genetheraengagement111008.htm NEW AUDITOR ENGAGEMENT LETTER W. T. Uniack & Co. CPA’s P.C. 12600 Deerfield Parkway Suite 100 Alpharetta, Georgia 30004 November 10, 2008 Mr. Antonio Milici Chief Executive Officer GeneThera Inc. Wheat Ridge, Colorado 80033 Dear Mr. Milici: We are pleased to confirm our understanding of the services we are to provide for GeneThera Inc. for the year ended Decem |
|
| November 19, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2008 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpora |
|
| November 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) NOVEMBER 14, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporation) 33-142603 (Commission File Number) 65-062 |
|
| November 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2008 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report |
|
| October 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 000-27237 65-0622463 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 17, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| October 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| September 9, 2008 |
13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Amendment #2 Under the Securities Exchange Act of 1934 Genethera, Inc. (Name of Issuer) Common Stock, par .001 (Title of Class of Securities) 37185E306 (CUSIP Number) August 31, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| August 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 13, 2008 |
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK OF GENETHERA, INC. |
|
| August 13, 2008 |
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK OF GENETHERA, INC. |
|
| August 13, 2008 |
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK OF GENETHERA, INC. |
|
| August 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 12, 2008 |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER EX-3 4 exhibit3211.htm EX-3 Exhibit 32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Antonio Milici, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly per |
|
| August 12, 2008 |
CERTIFICATION OF CHIEF FINANCIAL OFFICER Exhibit 32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly period ended June 30, 2008, |
|
| August 12, 2008 |
CERTIFICATION PURSUANT TO SECTION 302 EX-2 3 exhibit3121.htm EX-2 EXHIBIT 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Tannya L Irizarry, certify that: 1. I have reviewed this Form 10-QSB for the fiscal year ended June 30, 2008 of GeneThera, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the state |
|
| August 12, 2008 |
CERTIFICATION PURSUANT TO SECTION 302 EXHIBIT 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Antonio Milici, certify that: 1. I have reviewed this Form 10-Q for the fiscal quarter ended June 30, 2008 of GeneThera, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the ci |
|
| August 12, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2008 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation |
|
| June 19, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 12, 2008 |
SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 12, 2008 |
SCHEDULE 14C/A INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. |
|
| June 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2007 Commission File Number: GeneThera, Inc. (Exact name of registrant as Specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (Internal Revenue Service Incorporation or |
|
| May 30, 2008 |
May 29, 2008 Mr. John L. Krug Mail Stop 0610 United States Securities and Exchange Commission 450 Fifth Street N.W. Washington, D.C. 20548 Re: GeneThera, Inc.. Revised Preliminary Information statement filed May 29, 2008 File No. 0-27237 Dear Mr. Krug, Thank you for the comment letter sent by your department on May 29, 2008. Following are GeneThera’s responses to your comments. For your convenienc |
|
| May 29, 2008 |
May 29, 2008 Mr. John L. Krug Mail Stop 0610 United States Securities and Exchange Commission 450 Fifth Street N.W. Washington, D.C. 20548 Re: GeneThera, Inc.. Preliminary Information statement filed May 23, 2008 File No. 0-27237 Dear Mr. Krug, Thank you for the comment letter sent by your department on May 28, 2008. Following are GeneThera’s responses to your comments. For your convenience, each |
|
| May 29, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 INFORMATION STATEMENT SCHEDULE 14C (RULE 14C-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement GENETHERA, INC. |
|
| May 23, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 INFORMATION STATEMENT SCHEDULE 14C (RULE 14C-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14(c) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement GENETHERA, INC. |
|
| May 22, 2008 |
CERTIFICATION OF CHIEF FINANCIAL OFFICER Exhibit 99 Exhibit 99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly period ended Mar |
|
| May 22, 2008 |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER Exhibit 99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Antonio Milici, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly period ended March 31, 2008, fu |
|
| May 22, 2008 |
SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 21, 2008 |
CERTIFICATION OF CHIEF FINANCIAL OFFICER Exhibit 99 Exhibit 99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly period ended Mar |
|
| May 21, 2008 |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER Exhibit 99 Exhibit 99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Antonio Milici, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the quarterly period ended March 3 |
|
| May 21, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2008 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Nevada 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporation |
|
| May 15, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2008 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on F |
|
| May 8, 2008 |
Schedule 13G Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Amendment 1 Under the Securities Exchange Act of 1934 Genethera, Inc. (Name of Issuer) Common Stock, par .001 (Title of Class of Securities) 37185E207 (CUSIP Number) April 30, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| April 18, 2008 |
FORM 10-K FORM 10-K/A ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2007 Commission File No. |
|
| April 16, 2008 |
GENETHERA, INC. AND SUBSIDIARY (A Development Stage Company) GENETHERA, INC. AND SUBSIDIARY (A Development Stage Company) FINANCIAL STATEMENTS FOR THE PERIOD FROM OCTOBER 5, 1998 (INCEPTION) TO DECEMBER 31, 2007 GENETHERA, INC. AND SUBSIDIARY (A DEVELOPMENT STAGE COMPANY) CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD FROM OCTOBER 5, 1998 (INCEPTION) TO DECEMBER 31, 2007 TABLE OF CONTENTS Page No. Independent Registered Public Accounting Firm?s Report 2 C |
|
| April 16, 2008 |
Results of Operations and Financial Condition 8-K 1 f8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2008 GENETHERA, INC. (Exact name of registrant as specified in its charter) Nevada 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Com |
|
| March 31, 2008 |
NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 28, 2008 |
Form S-8 - July 17, 2006 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 25, 2008 REGISTRATION NO. |
|
| February 13, 2008 |
Schedule 13G Amendment No. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Genethera, Inc. Amendment #3 (Name of Issuer) Common Stock, par .001 (Title of Class of Securities) 37185E207 (CUSIP Number) December 31, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| January 8, 2008 |
January 7, 2008 Ibolya Ignat Mail Stop 6010 SEC Division of Corporation Finance Washington, DC 20549 Re: GeneThera, Inc. |
|
| December 7, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 AMENDMENT No. 2 GENETHERA INC. (Name of Issuer) Common Stock, Par ..001 (Title of Class of Securities) 37185E207 (CUSIP Number) November 30, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| November 30, 2007 |
FORM 10-KSB FORM 10-KSB/A ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2005 Commission File No. |
|
| November 30, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2007 GeneThera, Inc. (Exact name of registrant as specified in its charter) FLORIDA 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File |
|
| November 19, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of Incorporation of Orga |
|
| November 16, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: NOTIFICATION OF LATE FILING (Check One): ||Form 10-KSB ||Form 20-F ||Form 11-K [x] Form 10-QSB ||Form N-SAR For Period Ended: September 30, 2007 || Transition Report on Form 10-KSB || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-QSB || Tran |
|
| November 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number: NOTIFICATION OF LATE FILING (Check One): ||Form 10-KSB ||Form 20-F ||Form 11-K [x] Form 10-QSB ||Form N-SAR For Period Ended: September 30, 2007 || Transition Report on Form 10-KSB || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-QSB || Tran |
|
| November 13, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2007 GeneThera, Inc. (Exact name of registrant as specified in its charter) FLORIDA 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File |
|
| November 13, 2007 |
November 13, 2007 Ibolya Ignat, Staff Accountant Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, DC 20549 Re: Registrant: GeneThera, Inc. |
|
| November 9, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2006 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpora |
|
| November 9, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended September 30, 2006 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorp |
|
| November 8, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2006 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpor |
|
| November 8, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2007 GeneThera, Inc. (Exact name of registrant as specified in its charter) FLORIDA 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| November 7, 2007 |
Converted by EDGARwiz |
|
| October 22, 2007 |
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 19, 2007 REGISTRATION NO. |
|
| August 23, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpora |
|
| August 14, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended June 30, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporati |
|
| July 2, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): JUNE 29, 2007 GeneThera, Inc. (Exact name of registrant as specified in its charter) FLORIDA 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| June 15, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): JUNE 15, 2007 GeneThera, Inc. (Exact name of registrant as specified in its charter) FLORIDA 33-142603 65-0622463 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| June 15, 2007 |
GeneThera Receives NIH Contract Converted by EDGARwiz GeneThera Receives NIH Contract WHEAT RIDGE, CO - (MARKET WIRE) - June 12, 2007 - GeneThera, Inc. |
|
| June 15, 2007 |
GENETHERA HAS ENTERED INTO NEGOTIATIONS TO PROVIDE TESTING FOR MEZEY HOWARTH RACING STABLES GENETHERA HAS ENTERED INTO NEGOTIATIONS TO PROVIDE TESTING FOR MEZEY HOWARTH RACING STABLES WHEAT RIDGE, CO - (MARKET WIRE) – June 13, 2007 - GeneThera, Inc. |
|
| June 1, 2007 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) MAY 31, 2007 GENETHERA, INC. (Exact name of registrant as specified in its charter) FLORIDA (State or other jurisdiction of incorporation) 33-142603 (Commission File Number) 65-0622463 |
|
| June 1, 2007 |
GeneThera, Inc.’s Transfer Agent Requesting Beneficial Shareholders List from Brokerage Firms GeneThera, Inc.?s Transfer Agent Requesting Beneficial Shareholders List from Brokerage Firms Wheat Ridge, CO, May 31, 2007-MARKET WIRE-GeneThera, Inc.?s (OTCBB: GTHA - News) transfer agency in charge of processing transfers, GTI Corporate Transfer Agents, LLC announced their request for the brokerage firms to provide GTHA beneficial shareholders list as of record date May 21, 2007 in order to pay |
|
| May 25, 2007 |
Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) MAY 25, 2007 GENETHERA (Exact name of registrant as specified in its charter) FLORDIA (State or other jurisdiction of incorporation) 33-142603 (Commission File Number) 65-0622463 (IRS |
|
| May 18, 2007 |
Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) MAY 18, 2007 GENETHERA (Exact name of registrant as specified in its charter) FLORDIA (State or other jurisdiction of incorporation) 33-142603 (Commission File Number) 65-0622463 (IRS |
|
| May 18, 2007 |
GENETHERA ANNOUCES A CASH DIVIDEND Exhibit 99.1 GENETHERA ANNOUCES A CASH DIVIDEND WHEAT RIDGE, CO - (MARKET WIRE) - April 18, 2007 - GeneThera, Inc. (OTCBB: GTHA) announced today that it has declared a regular cash dividend of $.0004 per share on the company’s common stock. The dividend is payable on May 31, 2007, to stockholders of record as of the close of business on May 21, 2007. Genethera has approximately 38 million shares o |
|
| May 15, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpor |
|
| May 14, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorpor |
|
| May 14, 2007 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [ X ] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2007 Commission File No. 000-27237 GENETHERA, INC. (Exact name of small Business Issuer as specified in its Charter) Florida 65-0622463 (State or Other Jurisdiction of (I.R.S. Employer Incorporat |
|
| May 4, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GENETHERA, INC. (Exact name of Registrant as specified in its charter) Florida 65-0622463 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) 3930 Youngfield Wheat Ridge, Colorado 80033 (Address of Principal Executive |
|
| May 2, 2007 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10K-SB/A ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2006 Commission File No. 000-27237 GENETHERA, Inc. (Exact name of Registrant as specified in its charter) FLORIDA 65-0622463 (State or other jurisdiction of incorporation or formation) (I.R.S. employer ide |
|
| April 17, 2007 |
FORM 10-KSB ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2006 Commission File No. |
|
| April 12, 2007 |
GeneThera, Inc. 3930 Youngfield Street Wheat Ridge, CO 80033 GeneThera, Inc. 3930 Youngfield Street Wheat Ridge, CO 80033 303/463-6371 April 12, 2007 VIA EDGAR Securities and Exchange Commission Judiciary Plaza 450 Fifth Street, N.W. Washington, DC 20549 Re: GeneThera, Inc. (?Registrant?) filing on SB-2 File No. 333-136503 (the ?Filing?) Filed August 23, 2006 Please be advised that Registrant hereby requests withdrawal of the Filing on SB-2 File Number 333- |
|
| April 9, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 AMENDMENT No. 1 GENETHERA INC. (Name of Issuer) Common Stock, Par ..001 (Title of Class of Securities) 37185E207 (CUSIP Number) March 31, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| April 2, 2007 |
U.S. SECURITIES AND EXCHANGE COMMISSION U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NOTIFICATION OF LATE FILING FORM 12b-25 Sec. File Number 333-123138 Cusip Number 37185E [Check One] [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form -SAR For the Period Ended: December 31, 2006 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report |
|
| February 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT No. 2) GENETHERA, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 37185E207 (CUSIP Number) December 31, 2006 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule |
|
| February 14, 2007 |
Schedule 13G 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 GENETHERA, INC. (Name of Issuer) Common Stock, Par ..001 (Title of Class of Securities) 37185E207 (CUSIP Number) December 31, 2006 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| August 23, 2006 |
Mail Stop 6010 August 1821, 2006 Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N. |
|
| August 23, 2006 |
Registration No. 333-136503 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SB-2/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GeneThera, Inc. (Name of Small Business Issuer in its Charter) Florida 2836 65-0622462 (State of Other Jurisdiction of (Primary Standard Industrial (IRS Employer Incorporation or Organization) Classification Code Number) Identification No.) 3930 |
|
| August 23, 2006 |
August 23, 2006 Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N. |
|
| August 21, 2006 |
Registration No. 333-136503 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SB-2/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GeneThera, Inc. (Name of Small Business Issuer in its Charter) Florida 2836 65-0622462 (State of Other Jurisdiction of (Primary Standard Industrial (IRS Employer Incorporation or Organization) Classification Code Number) Identification No.) 3930 |
|
| August 18, 2006 |
Mail Stop 6010 August 18, 2006 Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N. |
|
| August 16, 2006 |
Exhibit 99.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Steven M. Grubner, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-QSB of GeneThera, Inc. for the quarterly period ended June 30, 2006 |
